Fluoride

Fluoride

SCHEMBL7750151

CCC1CNCCO1.F

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7097741 1.00
SCHEMBL12524834 1.00
SCHEMBL3168 1.00
SCHEMBL322796 1.00
Bromide SCHEMBL1608720 0.98
Hydrochloric Acid SCHEMBL3862781 0.98
Hydrochloric Acid SCHEMBL18528199 0.98
Ammonia Solution, Strong SCHEMBL331668 0.98
Water SCHEMBL7481154 0.98
SCHEMBL3663947 0.98

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0967965-A4 LOW FOAMING THERAPEUTIC TOOTHPASTES WITH IMPROVED CLEANING AND ABRASION PERFORMANCE WHITEHILL ORAL TECH INC (US) 2001-01-24 EP disclosed
EP-0967965-A1 LOW FOAMING THERAPEUTIC TOOTHPASTES WITH IMPROVED CLEANING AND ABRASION PERFORMANCE WHITEHILL ORAL TECHNOLOGIES INC. (US) 2000-01-05 EP disclosed
WO-1998004234-A1 LOW FOAMING THERAPEUTIC TOOTHPASTES WITH IMPROVED CLEANING AND ABRASION PERFORMANCE WHITEHILL ORAL TECHNOLOGIES, INC. (US) 1998-02-05 WO disclosed
EP-0297213-B1 ORAL TREATMENT AND USE OF AN ORAL COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 1991-02-20 EP disclosed
EP-0405682-A1 Dental remineralization Colgate-Palmolive Company (US) 1991-01-02 EP disclosed
EP-0395117-A2 Oral treatment and manufacture of an oral composition THE PROCTER & GAMBLE COMPANY (US) 1990-10-31 EP disclosed
EP-0345821-A1 Oral compositions THE PROCTER & GAMBLE COMPANY (US) 1989-12-13 EP disclosed
EP-0319516-A2 Oral compositions THE PROCTER & GAMBLE COMPANY (US) 1989-06-07 EP disclosed
EP-0297213-A2 Oral treatment and use of an oral composition THE PROCTER & GAMBLE COMPANY (US) 1989-01-04 EP disclosed
EP-0297212-A2 Oral compositions THE PROCTER & GAMBLE COMPANY (US) 1989-01-04 EP disclosed
EP-0297211-A2 Oral compositions THE PROCTER & GAMBLE COMPANY (US) 1989-01-04 EP disclosed